IRCT20201127049505N1已完成3 期
Comparison of the therapeutic effect of Sofosbuvir with Control group in outpatients with Covid-19 referred to outpatient clinics in Ahvaz
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Outpatients presented with positive PCR and mild clinical signs
- •without pulmonary involvement on CT scan
- •As defined by patient with sore throat
- •loss of sense of smell and taste
- •nausea and vomiting
- •O2 Sat = 95
- •stable pulse and blood pressure
排除标准
- •Organ transplant
- •Severe skin history including TEN or Steven JohnsonAllergy to the studied drug
- •The patient has previously been treated with this drug for other reasons
- •Hepatitis C
- •Not able to take pills
- •Lack of awareness
- •Be treated with anticonvulsant drugs
- •Have fever and respiratory symptoms from 2 weeks ago
- •Be treated with immunosuppressive drugs
- •Be pregnant or breastfeeding
- •1 month ago received antiviral drugs for Covid-19
- •Advance CKD
- •Advance liver disease
- •Pulmonary Advance Disease
- •Cardiac Advance Disease
- •Advance Disease Hematology
- •Solid tumor
- •Cancer of neurological diseases such as CVA
- •your situationG6PD deficient
- •Be pregnant or breastfeeding
研究者
相似试验
招募中
不适用
Evaluation of the efficacy of sofosbuvir and ribavirin for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000019469Toranomon Hospital100
招募中
不适用
Evaluation of the efficacy of sofosbuvir and velpatasvir in HCV-infected Japanese patients with decompensated cirrhosis: a prospective study in real life settings.decompensated cirrhotic patients with hepatitis C virusJPRN-UMIN000035711Toranomon Hospital100
招募中
不适用
Evaluation of the efficacy of sofosbuvir and ledipasvir for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000019468Toranomon Hospital100
招募中
2 期
Efficacy and safety of Sofosbuvir in the treatment of SARS-CoV-2: An Open Label phase II TrialSARS-CoV-2 ?associated SARI.SARS-CoV-2U07.1IRCT20200328046882N1Shahid Beheshti University of Medical Sciences60
招募中
不适用
Evaluation of the efficacy of sofosbuvir/velpatasvir and ribavirin in Japanese hepatitis C patients who failed direct-acting antiviral agents: a prospective study in real life settings.cirrhotic and non cirrhotic patients with hepatitis C virusJPRN-UMIN000035713Toranomon Hospital150